[Federal Register Volume 83, Number 217 (Thursday, November 8, 2018)]
[Notices]
[Page 55888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24462]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Office of Infectious Diseases (BSC, OID). This meeting is open to the 
public, limited only by the space available; the meeting room will 
accommodate up to 100 people. The public is also welcome to listen to 
the meeting by telephone, limited only by the number of ports available 
(50); the toll-free dial-in number is 1-877-951-7311, with a pass code 
of 4123441.

DATES: The meeting will be held on December 5, 2018, 8:30 a.m. to 5 
p.m., EST, and December 6, 2018, 8:30 a.m. to 12 p.m., EST.

ADDRESSES: CDC, Global Communications Center, 1600 Clifton Road NE, 
Building 19, Auditorium B3, Atlanta, Georgia 30329-4027; also 1-877-
951-7311, with a pass code of 4123441.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal 
Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia 
30329-4027, Telephone (404) 639-4840; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director, CDC; 
the OID, CDC; and the Directors of the National Center for Immunization 
and Respiratory Diseases, the National Center for Emerging and Zoonotic 
Infectious Diseases, and the National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, CDC, in the following areas: 
Strategies, goals, and priorities for programs; research within the 
national centers; and overall strategic direction and focus of OID and 
the national centers.
    Matters to be Considered: The agenda will include updates from the 
infectious disease national centers and the Center for Global Health 
along with focused discussions on recent outbreaks and affected 
populations. Reports back from two workgroups will also be given: (1) 
The Board's Food Safety Modernization Act Surveillance Working Group 
and (2) the Vector-borne Diseases Workgroup of the BSC, OID, and the 
Board of Scientific Counselors, National Center for Environmental 
Health/Agency for Toxic Substances and Disease Registry. Agenda items 
are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-24462 Filed 11-7-18; 8:45 am]
 BILLING CODE 4163-19-P